|
|
||||||||
1 Department of Nutrition, School of Medicine, The University of Tokushima, Tokushima 770-8503; 2 Department of Nursing, School of Medical Sciences, The University of Tokushima, Tokushima 770-8509; and 3 Kagome Research Institute, Kagome Company, Nishinasuno, Tochigi 329-2762, Japan
Quercetin is a typical
flavonoid present mostly as glycosides in plant foods; it has attracted
much attention for its potential beneficial effects in disease
prevention. In this study, we examined human volunteers after the
short-term ingestion of onion, a vegetable rich in quercetin
glucosides. The subjects were served diets containing onion slices
(quercetin equivalent: 67.6-93.6 mg/day) with meals for 1 wk.
Quercetin was only found in glucuronidase-sulfatase-treated plasma, and
its concentration after 10 h of fasting increased from 0.04 ± 0.04 µM before the trial to 0.63 ± 0.72 µM after the 1-wk
trial. The quercetin content in low-density lipoprotein (LDL) after
glucuronidase-sulfatase treatment corresponded to <1% of the
-tocopherol content. Human LDL isolated from the plasma after the
trial showed little improvement of its resistance to copper ion-induced
oxidation. It is therefore concluded that conjugated metabolites of
quercetin accumulate exclusively in human blood plasma in the
concentration range of 10
7 ~ 10
6 M
after the short-term ingestion of vegetables rich in quercetin glucosides, although these metabolites are hardly incorporated into
plasma LDL.
quercetin metabolites; quercetin glycosides; low-density lipoprotein oxidation; glucuronidation
This article has been cited by other articles:
![]() |
M. Amasheh, S. Schlichter, S. Amasheh, J. Mankertz, M. Zeitz, M. Fromm, and J. D. Schulzke Quercetin Enhances Epithelial Barrier Function and Increases Claudin-4 Expression in Caco-2 Cells J. Nutr., June 1, 2008; 138(6): 1067 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am. J. Clinical Nutrition, January 1, 2005; 81(1): 230S - 242S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A Kroon, M. N Clifford, A. Crozier, A. J Day, J. L Donovan, C. Manach, and G. Williamson How should we assess the effects of exposure to dietary polyphenols in vitro? Am. J. Clinical Nutrition, July 1, 2004; 80(1): 15 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Murota, S. Shimizu, S. Miyamoto, T. Izumi, A. Obata, M. Kikuchi, and J. Terao Unique Uptake and Transport of Isoflavone Aglycones by Human Intestinal Caco-2 Cells: Comparison of Isoflavonoids and Flavonoids J. Nutr., July 1, 2002; 132(7): 1956 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. A. Sesink, K. A. O'Leary, and P. C. H. Hollman Quercetin Glucuronides but Not Glucosides Are Present in Human Plasma after Consumption of Quercetin-3-Glucoside or Quercetin-4'-Glucoside J. Nutr., July 1, 2001; 131(7): 1938 - 1941. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |